Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Orthop Relat Res. 2010 Aug;468(8):2218-23. doi: 10.1007/s11999-010-1290-z. Epub 2010 Mar 12.

Medicine versus orthopaedic service for hospital management of hip fractures.

Author information

  • 1Division of General Internal Medicine, Penn State College of Medicine, Hershey, PA, USA. cchuang@psu.edu

Abstract

BACKGROUND:

Hospital care of patients with hip fractures often is managed primarily by either a medicine or orthopaedic service, depending on the institution. Whether complication rates, length of stay, or time to surgery differs on different services is unknown.

QUESTIONS/PURPOSES:

We therefore determined whether (1) perioperative complication rates, and (2) length of stay and time to surgery for patients undergoing surgical management of hip fractures differed by the specialty of the primary service.

PATIENTS AND METHODS:

We performed a retrospective cohort study at a university-based academic hospital of patients undergoing surgery for hip fracture admitted to medicine and orthopaedic services during 2006. Of the 98 patients included in the analysis, 34% were managed by a medicine service and 66% by orthopaedics. Using multivariable regression models to adjust for patient characteristics and comorbidities, we determined whether service designation predicted the likelihood of severe or intermediate perioperative complications, length of stay, or time to surgery.

RESULTS:

The rate of severe or intermediate complications for patients undergoing surgical management of hip fractures was 30%. Patients with medicine or orthopaedic services did not differ in the rate of severe or intermediate complications or length of stay in adjusted analysis. However, time to surgery was longer in patients managed by the medical service in adjusted analysis.

CONCLUSIONS:

In our patient cohort, the likelihood of perioperative complications occurring among patients with hip fractures did not differ by service designation in adjusted analysis.

LEVEL OF EVIDENCE:

Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

PMID:
20224961
PMCID:
PMC2895834
DOI:
10.1007/s11999-010-1290-z
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center